Together, these xenograft experiments using the 22Rv1 and PC-3 models support the hypothesis that GCN2 provides significant growth advantages to PCa and suggests a mechanism involving enhanced SLC transporter expression that is independent of AR expression. Here, EIF2AK4 is linked to posterior cortical atrophy.